Literature DB >> 17635151

Bax-inhibiting peptides derived from Ku70 and cell-penetrating pentapeptides.

J A Gomez1, V Gama, T Yoshida, W Sun, P Hayes, K Leskov, D Boothman, S Matsuyama.   

Abstract

We found that Ku70, a known DNA repair factor, has a novel function to bind and inhibit Bax (Bcl-2-associated X protein), a key mediator of apoptosis. Pentapeptides derived from the Bax-binding domain of Ku70 were cell-permeable and protected cells from Bax-mediated apoptosis. These pentapeptides were called BIPs (Bax-inhibiting peptides). BIPs may become a useful therapeutic tool to reduce cellular damage. We also generated BIP mutant pentapeptides that do not inhibit Bax, but retain their cell-penetrating activity. Since both BIPs and BIP mutants are cell-permeable, these peptides were designated CPP5s (cell-penetrating pentapeptides). Among the CPP5s discovered, VPTLK (BIP) and KLPVM (BIP mutant) were confirmed to possess protein transduction activity by examination of the delivery of GFP (green fluorescent protein) into cells by these peptides. The mechanism of cell penetration by CPP5s is not known. CPP5s enter the cell at 0 and 4 degrees C. In preliminary studies, various inhibitors of endocytosis and pinocytosis did not show any significant suppression of CPP5 cell entry. CPP5s have very low toxicity in vitro and in vivo and so may be useful tools in order to develop non-toxic drug-delivery technologies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17635151     DOI: 10.1042/BST0350797

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  43 in total

1.  CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.

Authors:  Konstantin S Leskov; Shinako Araki; John-Paul Lavik; Jose A Gomez; Vivian Gama; Efstathios S Gonos; Ioannis P Trougakos; Shigemi Matsuyama; David A Boothman
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

2.  Ku70 is stabilized by increased cellular SUMO.

Authors:  Vyacheslav Yurchenko; Zhu Xue; Vivian Gama; Shigemi Matsuyama; Moshe J Sadofsky
Journal:  Biochem Biophys Res Commun       Date:  2007-12-04       Impact factor: 3.575

3.  Regulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation.

Authors:  Avigail D Amsel; Moran Rathaus; Noam Kronman; Haim Y Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

4.  A MedChem toolbox for cereblon-directed PROTACs.

Authors:  Christian Steinebach; Izidor Sosič; Stefanie Lindner; Aleša Bricelj; Franziska Kohl; Yuen Lam Dora Ng; Marius Monschke; Karl G Wagner; Jan Krönke; Michael Gütschow
Journal:  Medchemcomm       Date:  2019-05-28       Impact factor: 3.597

5.  Deletion of Ku70, Ku80, or both causes early aging without substantially increased cancer.

Authors:  Han Li; Hannes Vogel; Valerie B Holcomb; Yansong Gu; Paul Hasty
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

Review 6.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

Review 7.  Therapeutic modulation of apoptosis: targeting the BCL-2 family at the interface of the mitochondrial membrane.

Authors:  Kathleen N Nemec; Annette R Khaled
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

8.  Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization.

Authors:  V Gama; J A Gomez; L D Mayo; M W Jackson; D Danielpour; K Song; A L Haas; M J Laughlin; S Matsuyama
Journal:  Cell Death Differ       Date:  2009-02-27       Impact factor: 15.828

9.  Proinflammatory cytokines activate the intrinsic apoptotic pathway in beta-cells.

Authors:  Lars G Grunnet; Reid Aikin; Morten F Tonnesen; Steven Paraskevas; Lykke Blaabjerg; Joachim Størling; Lawrence Rosenberg; Nils Billestrup; Dusica Maysinger; Thomas Mandrup-Poulsen
Journal:  Diabetes       Date:  2009-05-26       Impact factor: 9.461

10.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.